This site is intended for healthcare professionals
Login
Register
Medical education
Specialty
Drugs
News
Congresses
Search
Menu
Medical education
Specialty
Drugs
News
Congresses
Personalised to support your treatment decisions
Find disease awareness content and supporting materials, including relevant drugs
0
results found
Welcome:
Register to view statistics -
Register
Updates in your area
of interest
Articles your peers
are looking at
Bookmarks
saved
Days to your
next event
Learning Zones
Overview
Managing High-Risk NMIBC
1 mins
Prostate Cancer Nexus
1 mins
Overview
Chronic Inflammatory Demyelinating Polyneuropathy
1 mins
Learning Zone
HRR mutation testing in mPC
1 mins
Overview
Atopic Dermatitis in Paediatric Patients
1 mins
Learning Zone
Chronic Spontaneous Urticaria Academy
1 mins
Learning Zone
Type 2 Inflammation in COPD
1 mins
Learning Zone
Advances in Lymphoma
1 mins
Learning Zone
THINK THROMBOSIS: Individualised care
1 mins
Learning Zone
Advances in HS
30 mins
Learning Zone
Type 2 Inflammation in Upper & Lower Airway Diseases
1 mins
Overview
Treatment selection in HIV Learning Zone
125 mins
Learning Zone
Hidradenitis Suppurativa Academy
120 mins
Learning Zone
Psoriasis Academy
910 mins
Learning Zone
Myasthenia Gravis Learning Zone
110 mins
Learning Zone
Growth Hormone Deficiency
150 mins
Learning Zone
Alopecia areata Learning Zone
60 mins
Learning Zone
Severe Asthma Learning Zone
100 mins
Learning Zone
mCRPC in focus
1 mins
Learning Zone
Complement-mediated kidney diseases
205 mins
Learning Zone
Pompe Disease: Key findings from WMS 2022
150 mins
Learning Zone
Supportive care in oncology Learning Zone
150 mins
Learning Zone
Albumin in fluid management
115 mins
Learning Zone
Glaucoma Learning Zone
190 mins
Learning Zone
Antiplatelet therapy in ACS: Choices and Controversies
270 mins
Learning Zone
Chronic Kidney Disease Learning Zone
340 mins
Learning Zone
Hidradenitis suppurativa
220 mins
Learning Zone
Multiple Sclerosis (MS) Learning Zone
160 mins
Webinars
Learning Zone
Recurrence in early breast cancer
40 mins
Latest news
News
FDA approves Tremfya (guselkumab), the first and only IL-23 inhibitor offering both subcutaneous and intravenous induction options, for adult patients with Crohn’s disease - Johnson & Johnson
News
EARTH-HCM, a public health education tool for the hypertrophic cardiomyopathy community, is launched - Cytokinetics
Industry news
Eyenovia and Betaliq to Merge
Eyenovia Inc. and Betaliq Inc. announce merger to form a new ophthalmic company.
See all news
Guidelines
Guideline
Current clinical management of CIDP with immunoglobulins in France: An expert opinion
1 mins
Guideline
French recommendations for the management of adult & pediatric CIDP
1 mins
Guideline
European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy
1 mins
Guideline
Diagnostic guidelines for familial hemophagocytic lymphohistiocytosis revisited
1 mins
Guideline
Consensus-based guidelines for the recognition, diagnosis, and management of hemophagocytic lymphohistiocytosis in critically ill children and adults
1 mins
Guideline
Diagnosis and investigation of suspected haemophagocytic lymphohistiocytosis in adults: 2023 HiHASC consensus guideline
1 mins
Guideline
The 2022 EULAR/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS)
1 mins
Guideline
Monitoring patients with eosinophilic esophagitis in routine clinical practice - International expert recommendations - EUREOS
1 mins
Guideline
2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19
1 mins
Guideline
Assessment of adult women with ovarian masses and treatment of epithelial ovarian cancer: ASCO resource-stratified guideline
1 mins
Guideline
Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: ASCO guideline update
1 mins
Guideline
PARP Inhibitors in the management of ovarian cancer: ASCO guideline rapid recommendation update
1 mins
Guideline
Updated treatment recommendations for prostate cancer from the ESMO Clinical Practice Guideline considering treatment intensification and use of novel systemic agents
1 mins
Guideline
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with prostate cancer
1 mins
Guideline
The 1st EoETALY Consensus on the diagnosis and management of eosinophilic esophagitis - Current treatment and monitoring
1 mins
Guideline
The 1st EoETALY Consensus on the diagnosis and management of eosinophilic esophagitis - Definition, clinical presentation and diagnosis
1 mins
Guideline
S2k guideline Gastroesophageal reflux disease and eosinophilic esophagitis of the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS)
1 mins
Guideline
Diagnosis and management of eosinophilic esophagitis in children: An update from the ESPGHAN
1 mins
Guideline
ACG clinical guideline: Diagnosis and management of eosinophilic esophagitis
1 mins
Guideline
SDBP Clinical practice guideline for the assessment and treatment of children and adolescents with complex ADHD
1 mins
Guideline
2024 European Society of Hypertension clinical practice guidelines for the management of arterial hypertension
1 mins
Guideline
2024 ESC Guidelines for the management of elevated blood pressure and hypertension
1 mins
Guideline
Systematic review-based guideline “Parkinson’s disease” of the German Society of Neurology: diagnostic use of transcranial sonography
1 mins
Guideline
Guideline “Parkinson’s disease” of the German Society of Neurology (Deutsche Gesellschaft für Neurologie): concepts of care
1 mins
Guideline
Diagnostics and treatment of impulse control disorders, psychosis and delirium: systemic review-based recommendations - guideline “Parkinson’s disease” of the German Society of Neurology
1 mins
Events
Event
EAACI 2025
1 mins
Event
EHA2025
1 mins
Event
EADV 2025
1 mins
Event
2025 AAN Annual Meeting
1 mins
Event
EAU 2025
1 mins
Event
ESMO Breast Cancer 2025 Annual Congress
1 mins
Event
ASCO 2025 Annual Meeting
1 mins
Top